Free Trial
NASDAQ:AKAN

Akanda Q4 2025 Earnings Results & Report

Akanda logo
$1.77 -0.01 (-0.51%)
As of 09:49 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Akanda reported Q4 2025 earnings on June 9, 2026. The company reported EPS of -$317.90.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
After Market Closes

Akanda EPS Results

Actual EPS
-$317.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Akanda Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Akanda Q4 2025 Earnings FAQ

Akanda (NASDAQ:AKAN) reported earnings of -$317.90 per share for Q4 2025. The report was announced on Tuesday, June 9, 2026.

Akanda Earnings Headlines

Akanda (NASDAQ:AKAN) Stock Lifted to Sell by Wall Street Zen
Akanda (NASDAQ:AKAN) Announces Quarterly Earnings Results
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
See More Akanda Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Akanda? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Akanda and other key companies, straight to your email.

About Akanda

Akanda (NASDAQ:AKAN) is an international medical cannabis company headquartered in London, England. The company has focused on building a supply chain for medical cannabis, including cultivation, processing, importing and distribution, with an emphasis on serving regulated markets.

Akanda’s business has included CanMart, a United Kingdom-based pharmaceutical importer and distributor that supplies medical cannabis products to pharmacies, clinics and patients through the country’s regulated framework. The company has also been associated with Holigen, a Portugal-based cannabis business involved in cultivation and production activities intended to support European medical cannabis markets.

Akanda was established to develop a vertically integrated cannabis platform serving patients and healthcare markets in Europe. Its operations and commercial relationships have primarily centered on the United Kingdom and Portugal, while its publicly traded shares are listed on the Nasdaq under the symbol AKAN.

View Akanda Profile